SPOTLIGHT -
The Benefits of a New Therapy for Pompe Disease: Tahseen Mozaffar, MD, FAAN
On Rare Disease Day, the director of the Division of Neuromuscular Diseases at UC Irvine commented on the potential of AT845 for this patient population. [WATCH TIME: 3 minutes]
Interim FORTIS Study Safety Data for AT845 in Adults With Late-Onset Pompe Disease: Tahseen Mozaffar, MD, FAAN
The director of the Division of Neuromuscular Diseases at UC Irvine discussed the positive data, noting that the treatment was “incredibly safe.” [WATCH TIME: 4 minutes]
